Individuals with diabetes are at a heightened risk for development of infections, including skin/soft tissue infections, urinary tract infections, and lower respiratory tract infections, as well as more complex and rare infections. Research has established that among those with diabetes, especially those with poorly controlled disease, there is a greater risk for the development of infections and related complications due to a complex interplay between various factors, which can be classified as systemic and local host factors and/or specific pathogens. Findings have revealed that infections in those with diabetes are often correlated with increased rates of hospitalization, durations of stay, and complications. Pharmacists are well poised to educate patients about the augmented risk for infection. They can also provide patients with pertinent information regarding measures to reduce or prevent these infections, including clinical guidelines that recommend eligible individuals with diabetes obtain pneumonia, influenza, and COVID-19 vaccines. Pharmacists can also emphasize the importance of adherence to therapy and nutritional plans and the impact of tight glycemic control to lessen their risks.
展开▼
